Post-approval studies (Phase 4)Study completedNCT02954692
What this trial is testing
Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 112